A. Limitations
So far we have seen a new approach of using stemcells for targeting cancer site and a new concept of
treatment. However it might seem fascinating, it is important to note that significant impediments remain
before the true potential of this novel therapy can be fully realized. Here in this section we are going to
mainly focus on the limitations of neuralstemcells esp
neural progenitor cell이 pancreatic cell lineage line으로 분화될 수 있음을 보여준다.
해당 연구가 진행되었던 배경은 인슐린을 생산하는 섬세포(islet cell)는 신경단위세포(neuron)와 유사하다는 점과 배아 줄기세포(embryonic stemcell)를 인슐린 생산 세포로 변환시킨 선행 연구 사례를 통해 neural progenitor cell을 이용하
Mid-1800s - Beginning research of Embryo
1908 – ‘StemCell’ from Alexander Maksimov
1963 – Self reproducing cell
1978 – Found Blood stemcell
1981 - Embryonic stemcell
1998 - Human's embryonic stemcell
2001 – First human embryo cloning
(중략)
2.1 Adult StemCell - How?From Bone Marrow
HSCs and MSCs are rich in b
Stemcell calssification
1. Based upon location
Embryonic stemcells
Somatic/ adult stemcells
2. Based upon function
Totipotent
Pluripotent
Multipotent
Unipotent
Reject Response
Traditional Immuno-repressents
Constant administration
Little engraftment after 3~4 weeks
Host immune system impaired
Vulnerable to Infection
↓Need brief immuno-re
1908 - The term "stemcell" was proposed for scientific use by the Russian histologist Alexander Maksimov (1874–1928) at congress of hematologic society in Berlin. It postulated existence of haematopoietic stemcells.
1998 - James Thomson and coworkers derive the first human embryonic stemcell line at the University of Wisconsin–Madison.
2004–2005 - Korean researcher Hwan